8Goff BA,Sainz D,Mudlz H,et al.Clear cell carcinoma of the ovary:a distinct histologic type with poor prognosis and resistance to platinum_based chemotherapy in stage Ⅲ disease[J].Gynecol Oncol,1996,60(3):412 被引量:1
3Hart WR. Pathology of malignant and bordline epithelial tumors of ovary. In :Coppleson M(eds). Gynecologic Oncology Fundamental Principles and Clinical Practice. New York: Churchill Livingstone, 1992.863-887. 被引量:1
4Kennedy AW, Biscotti CV, Hare WR, et al. Ovarian clear cell adenocarcinoma. Gynecol Oncol, 1989,32: 342-349. 被引量:1
5Jiang X, Mortand SJ. Hitchcock A, et al. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res, 1998,58:1707-1712. 被引量:1
6Fukunaga M, Nomura K, Ishikawa E, et al. Ovarian atypical endometriosis: its association with malignant epithdial tumors. Histopathology, 1997, 30: 249-255. 被引量:1
7Sugiyama T, Kmura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovarian: a distinct histologic type with poor prognosis and resistant to platinum-based chemotherapy. Cancer,2000,88:2584-2589. 被引量:1
8Behbakht K, Randall TC, Benjamin I, et al. Clinical characteristics of clear cell carcionoma of the ovary. Gynecol Oncol, 1998,70:255-258. 被引量:1
9International federation of gynecology and obstetrics annual report on the results of treatment in gynecological cancer. Int Gynecol Obstet,1989,28:1189. 被引量:1
10Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. In: Sobin LH, ed. World Health Organization Interational Histological Classification of Tumors. Berlin: Springer-Verlag, 1994. 被引量:1
1Sugiyama T,Kamura T,Kigawa J,et al.Clinical characteristics of clear cell carcinoma of the ovary:a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy[J].Cancer,2000,88(11):2584-2589. 被引量:1
2Takano M,Sugiyama T,Yaegashi N,Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin:retrospective analysisJ].Clinical Oncology,2007,12(4):256-260. 被引量:1
3Takano M,Kikuchi Y,Yaegashi N,et al.Clear cell carcinoma of the ovary:a retrospective multicentre experience of 254 patients with complete surgical staging[J].Cancer,2006,94(10):1369-1374. 被引量:1
4Blurnenfeld Z1.Hormonal suppressive therapy for endometriosis may not improve patient healthy[J].Fertil Steril,2004,81(3):487-492. 被引量:1
5Chan JK,Teoh D,HuJM,et al.Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers[J].Gynecologic Oncology,2008,109(3):370-376. 被引量:1
6Mizuno M,Kikkawa F,Shibata K,et al.Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary[J],surgical Oncology,2006,94(2):138-443. 被引量:1
7Mayordomo JI,Andres R,Isla MD,et al.Results of a pilot trial of immunotherapy with dendritic cells pulsed with autolognus tumor lysates in patients with advanced cancer[J].Tumor,2007,93 (1):26-30. 被引量:1
8Nagai Y,Inamine M,Hirakawa M,et al.Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary[J].Gynecol Oncol,2007,107(3):469-473. 被引量:1
9Cloven NG,Kyshtoobayeva A,Burger RA,et al.In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancerl[J].Gynecological Cancer,2004,92(1):160-166. 被引量:1
10Utsunomiya H,Akahira J,Tanno S.Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma:a multicenter trial[J].Gynecological Cancer,2006,16(1):52-56. 被引量:1